Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Immunology and Allergy ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Poorly controlled asthma during pregnancy remains common in the United States.J Allergy Clin Immunol In Pract. 2019; 7: 2672-2680. e2610
- Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital.Aust N Z J Obstet Gynaecol. 2011; 51: 333-338
- Asthma during pregnancy in a population-based study-pregnancy complications and adverse perinatal outcomes.PLoS One. 2014; 9
- Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys.Ann Epidemiol. 2003; 13: 317-324
- Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy.Matern child Health J. 2013; 17: 1611-1621
- The risk of maternal and placental complications in pregnant women with asthma: a systematic review and meta-analysis.J Maternal-Fetal Neonatal Med. 2014; 27: 934-942
- Effect of pregnancy in asthma on health care use and perinatal outcomes.J Allergy Clin Immunol. 2015; 136: 1215-1223. e1216
- A meta-analysis of adverse perinatal outcomes in women with asthma.BJOG: An Int J Obstet Gynaecol. 2011; 118: 1314-1323
- Global Strategy for Asthma Management and Prevention.Global Initiative for Asthma. 2020;
- ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy.Obstet Gynecol. 2008; 111: 457-464
- Assessment of knowledge and education relating to asthma during pregnancy among women of childbearing age.Asthma Res Pract. 2018; 4: 1-5
- Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma.J Asthma. 2011; 48: 1032-1040
- Asthma education and outcomes for women of childbearing age.Case manager. 2003; 14: 58-61
- Management of asthma in pregnant women by general practitioners: a cross sectional survey.BMC Fam Pract. 2011; 12: 1-7
- Asthma, asthma medications and their effects on maternal/fetal outcomes during pregnancy.Reprod Toxicol. 2011; 32: 189-197
- Fetal Outcomes Among Women with Asthma during Pregnancy: Evidence from a Large Healthcare Database in the United States.J Allergy Clin Immunol. 2019; 143: AB422
- Use of asthma medication during pregnancy and risk of specific congenital anomalies: a European case-malformed control study.J Allergy Clin Immunol. 2015; 136: 1496-1502. e1497
- Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women.J Allergy Clin Immunol. 2008; 121: 1379-1384. e1371
- A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses.Am J Obstet Gynecol. 1994; 171: 392-399
- Genetic and epigenetic insights into fetal alcohol spectrum disorders.Genome Med. 2010; 2: 1-8
- Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis.Birth Defects Res A: Clin Mol Teratology. 2006; 76: 723-730
- Cleft lip and palate.Lancet. 2009; 374: 1773-1785
- Teratogen update: methotrexate.Birth Defects Res Part A: Clin Mol Teratology. 2012; 94: 187-207
- Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study.Am J Psychiatry. 2014; 171: 785-794
- Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.BMC Med. 2017; 15: 1-20
- Are animal models predictive for humans?.Philos Ethics humanities Med. 2009; 4: 1-20
- Drugs as teratogens.CRC press, Cleveland1976
- Factors Associated with Nonadherence to Inhaled Corticosteroids for Asthma During Pregnancy.The J Allergy Clin Immunol In Pract. 2021; 9: 1242-1252. e1241
- The relationship of asthma medication use to perinatal outcomes.J Allergy Clin Immunol. 2004; 113: 1040-1045
- Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes.Thorax. 2006; 61: 169-176
- Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study.Eur Respir J. 2020; 55
- Inhaled corticosteroids during pregnancy: a review of methodologic issues.Respir Med. 2008; 102: 862-875
- The safety of asthma and allergy medications during pregnancy.J Allergy Clin Immunol. 1997; 100: 301-306
- Outcome of pregnancy in a randomized controlled study of patients with asthma exposed to budesonide.Ann Allergy Asthma Immunol. 2005; 95: 566-570
- Asthma medication use in pregnancy and fetal growth.J Allergy Clin Immunol. 2005; 116: 503-509
- Severity of asthma and perinatal outcome.Am J Obstet Gynecol. 1992; 167: 963-967
- Perinatal outcomes in women with asthma during pregnancy.Obstet Gynecol. 1998; 92: 435-440
- Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy.Am J Obstet Gynecol. 2004; 190: 737-744
- Preliminary experience with triamcinolone acetonide during pregnancy.J Maternal-Fetal Med. 1996; 5: 310-313
- Congenital malformations after the use of inhaled budesonide in early pregnancy.Obstet Gynecol. 1999; 93: 392-395
- Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications.Eur J Clin Pharmacol. 2007; 63: 363-373
- Maternal drug use in early pregnancy and infant cardiovascular defect.Reprod Toxicol. 2003; 17: 255-261
- Use of inhaled steroids by pregnant asthmatic women does not reduce intrauterine growth.J Allergy Clin Immunol. 2004; 113: 427-432
- Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma.Thorax. 2007; 62: 320-328
- Use of drugs during pregnancy—unique Swedish registration method that can be improved.Inf Swedish Med Prod agency. 1999; 1: 8-11
- A population-based prescription study of asthma drugs during pregnancy: changing the intensity of asthma therapy and perinatal outcomes.Respiration. 2001; 68: 256-261
- High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations.J Allergy Clin Immunol. 2009; 124: 1229-1234. e1224
- Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide.J Allergy Clin Immunol. 2003; 111: 736-742
- A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide.Curr Med Res Opin. 2005; 21: 1075-1084
- A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.Am J Respir Crit Care Med. 1994; 149: 604-610
- Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy–a cohort linkage study.BJOG: An Int J Obstet Gynaecol. 2016; 123: 1609-1618
- Beta2-agonists use during pregnancy and perinatal outcomes: a systematic review.Respir Med. 2014; 108: 9-33
- Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.Ann Allergy Asthma Immunol. 2014; 112: 459-464
- Paradigm shift in the management of mild asthma: Focus toward a patient centered approach.Can J Respir Crit Care Sleep Med. 2020; 4: 55-60
- Asthma maintenance and reliever therapy: Should this be the standard of care?.Ann Allergy Asthma Immunol. 2020; 125: 150-155
- Risk of congenital malformations for asthmatic pregnant women using a long-acting β2-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.J Allergy Clin Immunol. 2015; 135: 123-130. e122
- Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.Teratology. 2000; 62: 385-392
- Corticosteroid use and risk of orofacial clefts.Birth Defects Res Part A: Clin Mol Teratology. 2014; 100: 499-506
- Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997–2011.J Allergy Clin Immunol In Pract. 2020; 8: 3490-3499.e9
- Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.Thorax. 2015; 70: 647-652
- Safety of antileukotriene agents in asthma management.Ann Allergy Asthma Immunol. 2001; 86: 18-23
- Fetal exposure to montelukast and congenital anomalies: a population based study in Denmark.Birth defects Res. 2017; 109: 452-459
- Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes.Eur J Clin Pharmacol. 2009; 65: 1259-1264
- Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma: A Systematic Review and Meta-analysis.JAMA. 2021; 325: 2466-2479
- NAEPP expert panel report: managing asthma during pregnancy: recommendations for pharmacologic treatment—2004 update.J Allergy Clin Immunol. 2005; 115: 34-46
- Theophylline in asthma.N Engl J Med. 1996; 334: 1380-1388
- Theophylline.Am J Of Respir And Crit Care Med. 2013; 188: 901-906
- Genentech. Xolair (omalizumab): full prescribing information.(Available at:) (Accessed)
- Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort.J Allergy Clin Immunol. 2020; 145 (e521): 528-536
- Biomarkers for severe eosinophilic asthma.J Allergy Clin Immunol. 2017; 140: 1509-1518
Glaxosmithkline. Nucala (mepolizumab): summary of product characteristics. 2021.
- Reslizumab (Cinqair): an Interleukin-5 antagonist for severe asthma of the eosinophilic phenotype.P T. 2017; 42: 564
- (Astrazeneca. Fasenra (benralizumab): prescribing information. Available at:) (Accessed)
- Regeneron. Dupixent (dupilumab): prescribing information.(Available at:) (Accessed)
- A case of atopic eczema treated safely with dupilumab during pregnancy and lactation.J Eur Acad Dermatol Venereol. 2020; 34: e256-e257
- Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report.JAAD Case Rep. 2020; 6: 1051
- Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature.Case Rep Dermatol. 2021; 13: 248-256
European Medicines Agency (EMA): assessment report; dupilumab. 2017.
- Prognosis of a new pregnancy following previous spontaneous abortions.Eur J Obstet Gynecol Reprod Biol. 1991; 39: 31-36
- Subfertility and risk of spontaneous abortion.Am J Public Health. 2000; 90: 1452
European Medicines Agency (EMA): Summary of product characteristics. 2020.
- Regulation of Eosinophilia in Asthma—New Therapeutic Approaches for Asthma Treatment.Cells. 2021; 10: 817
- Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation.Nat Commun. 2013; 4: 1-10
Astrazeneca. Tezspire™(tezepelumab) prescribing information: 2021.
- Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.N Engl J Med. 2021; 384: 1800-1809
- Medication use in pregnancy: a cross-sectional, multinational web-based study.BMJ open. 2014; 4: e004365
Article info
Publication history
Published online: October 27, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
